Company attributes
Industry
B2X
Pitchbook URL
Spun Out From
Number of Employees (Ranges)
1 – 10
Full Address
Medeon Science Park, Inkubatorn, Per Albin Hanssons väg 41, Malmö, Sweden 20512, SE
Investors
Total Funding Amount (USD)
2,540,000
Latest Funding Round Date
March 2021
Latest Funding Type
Other attributes
Company Operating Status
Active
Abarceo is a preclinical stage company, a spinout of Lund University Diabetes Center. The company has expertise in the molecular and genetic causes of beta cell dysfunction in type 2 diabetes and has identified a novel diabetes target responsible for the dysfunction, VDAC-1.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
